Search results
Showing: 10 of 209
dm+d for pharmaceutical suppliers and manufacturers
Suppliers of medicinal products and medical devices have a key role to play in supporting the maintenance of and updating dm+d.
Listing products on dm+d is the only way for pharmaceutical suppliers and manufacturers to make sure their products…
Pharmacy First June 2025
This is a news article on behalf of the Department of Health and Social Care
The clinical protocols and patient group directions (PGDs) for the NHS Pharmacy First service were updated in June 2025 to include some changes to the gateway criteria.…
Drug reimbursement price changes
The Department of Health and Social Care has confirmed that the reimbursement prices for the following products has been redetermined, in the months as set out in the table, to reflect an increase in the NHS list price:
Product…
COVID-19 vaccination payment for primary care providers
Primary care networks (PCNs), acting on behalf of a group of GPs and community pharmacies, can claim payment for administering the COVID-19 vaccination.
Payments are processed by NHSBSA, acting on behalf of NHS England and NHS Improvement (NHSEI…
Sub ICB Locations
ICB restructure July 2022
From 1 July 2022, Integrated Care Boards (ICBs) have replaced Strategic Information Partnerships (STPs). Clinical Commissioning Groups (CCGs) are now Sub-ICB Locations (SICBLs).
You can find more information about these…
FP34C submission to move to MYS in April
From April (for prescriptions dispensed in March 2022) all pharmacy contractors must submit their FP34C through the Manage Your Service (MYS) portal.
The change was announced in the September 2021 Drug Tariff. It means that, from April (for…
Endorsement guidance
Your endorsement of NHS prescriptions plays a vital role in making sure we have the correct information for reimbursement and remuneration.
Electronic Prescription Service Guidance for Endorsement (PDF: 526KB)
NCSO endorsements
No NCSO…
Community Pharmacy Assurance Framework (CPAF)
The Community Pharmacy Assurance Framework (CPAF) screening questionnaire 2025 to 2026 is now open
Find out more details in the 'Community Pharmacy Assurance Framework (CPAF) screening questionnaire 2025 to 2026 – Open' section on this page.…
NHS Community Pharmacy New Medicine Service (NMS) Expansion Pilot: Inclusion of Depression as a Therapeutic Area and Revised Service Delivery Model
This pilot will run from August 2022 until 31 March 2024, or before, if sufficient data has been collected to evaluate the service and commission nationally. Contractors will be notified of the end of the pilot with one month's notice of final…
Prescription form overprint specifications
It’s important that the overprint specifications for prescriptions are followed so all forms are printed to a high standard. This makes it much easier for us to process the forms quickly to meet deadlines.
Guidance on current and out of date…